31 results
Thumbnail

D2.490 - Consistent efficacy of a seasonal 300IR birch pollen sublingual immunotherapy in children and adolescents during worst pollen exposure: results of the YOBI trial

Thumbnail

D2.491 - Efficacy of a 300IR birch liquid sublingual immunotherapy during the alder and hazel pollen seasons: results of the YOBI trial

Thumbnail

D2.492 - Efficacy and safety of a 300IR daily dose of a SLIT of birch pollen allergen extract in children and adolescents with allergic rhinoconjunctivitis: results from the YOBI trial

Thumbnail

D2.494 - Tralokinumab treatment in adults with atopic dermatitis who were previously treated with dupilumab: 12-months real-world data from the TRACE study

Thumbnail

D2.495 - Treatment with Izicopan (INF904), an oral anti-C5aR inhibitor improves efficacy and safety in patients with chronic spontaneous urticaria: results from a Phase 2a study

Thumbnail

D2.496 - First-in-Human Phase I Clinical Outcomes of BxC-I17e Enriched with HSP70/miR-22-3p in Atopic Dermatitis

Thumbnail

D2.497 - Oral Deucrictibant Immediate-Release Capsule for On-Demand Treatment of Hereditary Angioedema Attacks: Results of the Phase 3 RAPIDe-3 Trial

Thumbnail

D2.498 - Berotralstat Decreased HAE Attacks Treated with On-Demand Therapy or Utilizing Professional Care in Pediatric Patients Aged 2 to

Thumbnail

D2.499 - Immunoregulatory Effects of Dupilumab Added to Omalizumab-Facilitated Multi-Allergen Oral Immunotherapy in the COMBINE clinical trial

Thumbnail

D2.503 - LP-003 Injection for the treatment of H1 Antihistamine-Inadequately Controlled Chronic Spontaneous Urticaria (CSU): A Multicenter, Randomized, Double-Blind, Controlled Phase Ⅱ Study

Thumbnail

D2.504 - Novel food supplement containing a combination of bioactive compounds in pediatric cow’s milk protein allergy: results from a randomized, placebo-controlled trial

Thumbnail

D3.243 - Food allergy in children with inherited epidermolysis bullosa: possible role of transcutaneous sensitization and features of the clinical course

Thumbnail

D3.240 - Differential microRNA expression in chronic spontaneous urticaria in relation to treatment response

Thumbnail

D3.241 - How Clinical Control of Chronic Urticaria influence in mental health

Thumbnail

D3.242 - SDRIFE induced by multiple systemic corticosteroids

Thumbnail

D3.244 - STK4 Deficiency Presenting with Epidermodysplasia Verruciformis

Thumbnail

D3.245 - Complete Resolution of Systemic Delayed Hypersensitivity following Removal of a Titanium Fixation Screw: A Case Report

Thumbnail

D3.246 - A Novel Mutation in a Case of Deficiency of Interleukin-1 Receptor Antagonist in a Filipino Male Child

Thumbnail

D3.247 - Skin Involvement Is One Of The Common Signs In Children With Inborn Errors Of Immunity

Thumbnail

D3.248 - Prospective Evaluation Of The Efficacy Of Janus Kinase Inhibitor Therapy In Children With Alopecia Areata And Atopic Dermatitis